Literature DB >> 21245394

Long-term in vivo imaging and measurement of dendritic shrinkage of retinal ganglion cells.

Christopher Kai-shun Leung1, Robert N Weinreb, Zhi Wei Li, Shu Liu, James D Lindsey, Nathan Choi, Lan Liu, Carol Yim-lui Cheung, Cong Ye, Kunliang Qiu, Li Jia Chen, Wing Ho Yung, Jonathan G Crowston, Mingliang Pu, Kwok Fai So, Chi Pui Pang, Dennis Shun Chiu Lam.   

Abstract

PURPOSE: To monitor and measure dendritic shrinkage of retinal ganglion cells (RGCs) in a strain of transgenic mice (Thy-1 YFP) that expresses yellow fluorescent proteins in neurons under the control of a Thy-1 promoter.
METHODS: A total of 125 RGCs from 16 eyes of Thy-1 YFP transgenic mice were serially imaged with a confocal scanning laser ophthalmoscope for 6 months after optic nerve crush. Quantitative analysis of cell body area, axon diameter, dendritic field, number of terminal branches, total dendritic branch length, branching complexity, symmetry, and distance from the optic disc was used to characterize the morphology of RGCs, describe the patterns of axonal and dendritic degeneration, identify the morphologic predictors for cell survival, and estimate the rate of dendritic shrinkage.
RESULTS: RGC damage was observed prospectively to begin with progressive dendritic shrinkage, followed by loss of the axon and the cell body. In a small proportion of RGCs, progressive axonal changes including fragmentation, beading, retraction, and bulb formation were also observed. RGCs with a larger dendritic field and a longer total dendritic branch length in general have a better survival probability. The rate of dendritic shrinkage was variable with a slower rate observed in cells having a larger dendritic field, a longer total dendritic branch length, and a greater distance from the optic disc.
CONCLUSIONS: Estimating the probability of RGC survival and measuring the rate of dendritic shrinkage could become a new paradigm for investigating neuronal degeneration and evaluating the response of neuroprotective treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245394     DOI: 10.1167/iovs.10-6012

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  48 in total

1.  Imaging of rat optic nerve axons in vivo.

Authors:  Jan C Koch; Johanna Knöferle; Lars Tönges; Uwe Michel; Mathias Bähr; Paul Lingor
Journal:  Nat Protoc       Date:  2011-11-03       Impact factor: 13.491

2.  Progressive degeneration of retinal and superior collicular functions in mice with sustained ocular hypertension.

Authors:  Hui Chen; Yan Zhao; Mingna Liu; Liang Feng; Zhen Puyang; Ji Yi; Peiji Liang; Hao F Zhang; Jianhua Cang; John B Troy; Xiaorong Liu
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-26       Impact factor: 4.799

Review 3.  In vivo imaging methods to assess glaucomatous optic neuropathy.

Authors:  Brad Fortune
Journal:  Exp Eye Res       Date:  2015-06-03       Impact factor: 3.467

4.  The optical detection of retinal ganglion cell damage.

Authors:  J E Morgan; J Tribble; J Fergusson; N White; I Erchova
Journal:  Eye (Lond)       Date:  2017-01-06       Impact factor: 3.775

Review 5.  Assessing retinal ganglion cell damage.

Authors:  C A Smith; J R Vianna; B C Chauhan
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

Review 6.  Advances in retinal ganglion cell imaging.

Authors:  S I Balendra; E M Normando; P A Bloom; M F Cordeiro
Journal:  Eye (Lond)       Date:  2015-08-21       Impact factor: 3.775

7.  Semi-automated, quantitative analysis of retinal ganglion cell morphology in mice selectively expressing yellow fluorescent protein.

Authors:  Ericka Oglesby; Harry A Quigley; Donald J Zack; Frances E Cone; Matthew R Steinhart; Jing Tian; Mary E Pease; Giedrius Kalesnykas
Journal:  Exp Eye Res       Date:  2011-12-22       Impact factor: 3.467

8.  Norrin treatment improves ganglion cell survival in an oxygen-induced retinopathy model of retinal ischemia.

Authors:  Wendy A Dailey; Kimberly A Drenser; Sui Chien Wong; Mei Cheng; Joseph Vercellone; Kevin K Roumayah; Erin V Feeney; Mrinalini Deshpande; Alvaro E Guzman; Michael Trese; Kenneth P Mitton
Journal:  Exp Eye Res       Date:  2017-08-18       Impact factor: 3.467

Review 9.  Evaluating retinal ganglion cell loss and dysfunction.

Authors:  Ben Mead; Stanislav Tomarev
Journal:  Exp Eye Res       Date:  2016-08-12       Impact factor: 3.467

10.  Nuclear atrophy of retinal ganglion cells precedes the bax-dependent stage of apoptosis.

Authors:  Katherine T Janssen; Caitlin E Mac Nair; Joel A Dietz; Cassandra L Schlamp; Robert W Nickells
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-11       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.